| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3390/IJMS20030705 |
| P953 | full work available at URL | https://www.mdpi.com/1422-0067/20/3/705 |
| P932 | PMC publication ID | 6387017 |
| P698 | PubMed publication ID | 30736365 |
| P50 | author | Yves Cottin | Q57304161 |
| P2093 | author name string | Yves Cottin | |
| Catherine Vergely | |||
| Eve Rigal | |||
| Marianne Zeller | |||
| Luc Rochette | |||
| Alexandre Meloux | |||
| P2860 | cites work | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| NT5E mutations and arterial calcifications | Q24607121 | ||
| Inflammation, oxidative stress and renin angiotensin system in atherosclerosis | Q26795756 | ||
| Cardiac matrix: a clue for future therapy | Q27026864 | ||
| Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity | Q28072147 | ||
| Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning | Q28080777 | ||
| Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21 | Q28084197 | ||
| Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. | Q54391573 | ||
| Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells | Q56964366 | ||
| Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo | Q59225172 | ||
| Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis | Q60912265 | ||
| The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification | Q60949633 | ||
| Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease | Q61849091 | ||
| Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation | Q64126438 | ||
| PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways | Q74308465 | ||
| Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy | Q79249946 | ||
| Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent | Q79435466 | ||
| Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice | Q79903873 | ||
| Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure | Q81730161 | ||
| Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores | Q86364990 | ||
| Inhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune Diseases | Q88839407 | ||
| CD73 as a potential opportunity for cancer immunotherapy | Q90580312 | ||
| TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction | Q90967417 | ||
| Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading | Q93345668 | ||
| A review of sarilumab for the treatment of rheumatoid arthritis | Q50086851 | ||
| Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy | Q50203941 | ||
| Lung pericyte-like cells are functional interstitial immune sentinel cells. | Q51141682 | ||
| Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand. | Q52661548 | ||
| Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability. | Q53203182 | ||
| High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | Q54348949 | ||
| Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors | Q28239524 | ||
| Vascular calcification: pathobiology of a multifaceted disease | Q28282418 | ||
| Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study | Q30314414 | ||
| The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis | Q30436462 | ||
| Relation of multiple inflammatory biomarkers to incident atrial fibrillation | Q33573035 | ||
| Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers | Q33695937 | ||
| OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice | Q33730470 | ||
| A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis | Q33991958 | ||
| Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond | Q34366449 | ||
| Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity | Q35035923 | ||
| A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study | Q35139150 | ||
| Endothelial cell metabolism in normal and diseased vasculature | Q35234625 | ||
| Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability | Q35279609 | ||
| Fatty acid carbon is essential for dNTP synthesis in endothelial cells | Q35548351 | ||
| Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton | Q35588952 | ||
| Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2. | Q36248821 | ||
| Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells | Q36265801 | ||
| Human pericytes for ischemic heart repair | Q36609495 | ||
| Immunology of Osteoporosis: A Mini-Review | Q36766801 | ||
| Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity | Q36835372 | ||
| Metabolic mechanisms in heart failure | Q36889876 | ||
| Energy metabolism in heart failure and remodelling | Q37090565 | ||
| GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation | Q37282297 | ||
| The ubiquitin-proteasome pathway and endothelial (dys)function | Q37600516 | ||
| TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice | Q37686619 | ||
| Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle. | Q37691786 | ||
| The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation | Q37784328 | ||
| Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts | Q38074961 | ||
| Vascular calcification: an update on mechanisms and challenges in treatment | Q38086058 | ||
| Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? | Q38122012 | ||
| Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes | Q38129182 | ||
| Diabetes, oxidative stress and therapeutic strategies | Q38218198 | ||
| Heparan sulphate as a regulator of leukocyte recruitment in inflammation. | Q38360333 | ||
| Tumor Necrosis Factor Related Apoptosis Inducing Ligand (Trail) in endothelial response to biomechanical and biochemical stresses in arteries | Q38479846 | ||
| Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration | Q38622247 | ||
| Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways | Q38707465 | ||
| Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting. | Q38710240 | ||
| The beneficial pleiotropic effects of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) within the vasculature: A review of the evidence | Q38734032 | ||
| The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis | Q38737178 | ||
| Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation | Q38738095 | ||
| Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL. | Q38754124 | ||
| Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance | Q38760809 | ||
| Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells | Q38771001 | ||
| Identification of novel therapeutic targets in the secretome of ionizing radiation‑induced senescent tumor cells | Q38807943 | ||
| Endothelial Mechanosignaling: Does One Sensor Fit All? | Q38888511 | ||
| Skeletal and cardiac muscle pericytes: Functions and therapeutic potential | Q38946672 | ||
| Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation | Q38947765 | ||
| Mitral valve endothelial cells with osteogenic differentiation potential. | Q38978261 | ||
| The Link Between Angiogenesis and Endothelial Metabolism | Q39043297 | ||
| Vascular ageing: Underlying mechanisms and clinical implications. | Q39380015 | ||
| IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus | Q39403443 | ||
| Vascular endothelial growth factor B controls endothelial fatty acid uptake. | Q39727853 | ||
| Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker. | Q40067017 | ||
| Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients. | Q40260672 | ||
| Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease | Q40343176 | ||
| Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages | Q40718834 | ||
| A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro | Q41017658 | ||
| Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition | Q41112182 | ||
| Adipose-derived stem cell-released osteoprotegerin protects cardiomyocytes from reactive oxygen species-induced cell death | Q41718620 | ||
| Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone | Q41881171 | ||
| Energy turnover of vascular endothelial cells | Q42442529 | ||
| Osteoprotegerin induces cytoskeletal reorganization and activates FAK, Src, and ERK signaling in endothelial cells. | Q43120907 | ||
| Mechanistic study of the proangiogenic effect of osteoprotegerin | Q43938558 | ||
| Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis | Q44486779 | ||
| Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand | Q44534331 | ||
| The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). | Q44574510 | ||
| NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells | Q44794854 | ||
| Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress | Q44937839 | ||
| RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway | Q46072800 | ||
| Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK-NRF2 pathway. | Q46371926 | ||
| Predictive ability of circulating osteoprotegerin as a novel biomarker for early detection of acute kidney injury induced by sepsis | Q46412957 | ||
| Association of osteoprotegerin with human abdominal aortic aneurysm progression | Q46531394 | ||
| Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin | Q46898246 | ||
| Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress | Q46989920 | ||
| The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review. | Q47386961 | ||
| Unraveling Binding Interactions between Human RANKL and Its Decoy Receptor Osteoprotegerin | Q47636814 | ||
| Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro. | Q47694388 | ||
| The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases | Q47862783 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| membrane protein | Q423042 | ||
| circulatory system | Q11068 | ||
| tissue | Q40397 | ||
| vascular disease | Q1266890 | ||
| cell surface receptor | Q2476074 | ||
| P304 | page(s) | 705 | |
| P577 | publication date | 2019-01-01 | |
| 2019-02-06 | |||
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | The Role of Osteoprotegerin and Its Ligands in Vascular Function | |
| P478 | volume | 20 |
| Q92277957 | Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients |
| Q99587324 | Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis |
| Q100490869 | Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients |
Search more.